Formulation and ingredients

DXM FAQ 1997: selective audit by topic

Immediate-release and extended-release DXM; additional ingredients in combination products.

Immediate and extended release

A modern description should name the formulation explicitly. DXM hydrobromide and polistirex have different profiles; absorption timing depends on the product and conditions.

Clarified

According to the 2026 audit · edition

Evidence and limitations

What was examined: The Delsym label describes an extended-release polistirex suspension. The Auvelity label distinguishes immediate-release DXM from extended-release bupropion.

Limits of the conclusion: Read the active-ingredient amount on the label together with the stated salt and formulation. Assessing bromide requires the actual product composition.

Sources: Delsym — polistirex label Chyka — clinical poisoning guideline Auvelity — current label

Historical paraphrase · FAQ 4.0 · 1997 · §9.5 The FAQ discusses rapid absorption of the ordinary formulation and prolonged release of polistirex.

This claim in the 2026 audit · Erowid archive (HTML 4.0-Y.1) · §9.5 · Pharmacokinetics: How DXM is Metabolized

Combination products: every ingredient matters

Assessment should use the complete ingredient list. Antihistamines, acetaminophen and other components have their own risks, which depend on the substance and exposure.

Clarified

According to the 2026 audit · edition

Evidence and limitations

What was examined: Monte examines serotonin toxicity in overdose involving DXM and chlorpheniramine. Chyka’s guideline separately requires consideration of accompanying product ingredients.

Limits of the conclusion: A subjective plateau category offers little help in assessing toxicity of additional ingredients. Their names and amounts are needed.

Sources: Monte — serotonin toxicity Chyka — clinical poisoning guideline

Historical paraphrase · FAQ 4.0 · 1997 · §6.1.3 The FAQ allows products with antihistamine ingredients below a particular plateau.

This claim in the 2026 audit · Erowid archive (HTML 4.0-Y.1) · §6.1.3 · Mild Allergic Reactions and Histamine Release

Sources for this topic
  1. Monte — serotonin toxicity — PubMed abstract
  2. Delsym — polistirex label — Official label

    The DailyMed label version published on 22 May 2026 was checked for formulation and ingredients.

  3. Chyka — clinical poisoning guideline — PubMed abstract
  4. Auvelity — current label — Official label

    Indications, ingredients, interactions and mechanism were checked in the label revised in August 2026.

All update topics · Review coverage

Reference

Open the source and related combinations →